Loading clinical trials...
Loading clinical trials...
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Patients With Neurogenic Orthostatic Hypotension
Conditions
Interventions
Midodrine Hydrochloride
Locations
15
United States
North Alabama Neuroscience Research
Huntsville, Alabama, United States
Dr. Harry Pepe & Associates, Inc.
Miramar, Florida, United States
Suncoast Neuroscience Associates, Inc.
St. Petersburg, Florida, United States
Economou & Associates, LTD
Chicago, Illinois, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Michigan Pain and Neurological Institute
Ann Arbor, Michigan, United States
Start Date
December 1, 1997
Primary Completion Date
November 24, 1999
Completion Date
November 24, 1999
Last Updated
June 11, 2021
NCT04369131
NCT03900000
NCT02963181
NCT02123303
NCT00117585
NCT01866787
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions